03:44 AM EST, 12/16/2024 (MT Newswires) -- Pharming Group ( PHAR ) said Sunday its subsidiary has launched a recommended public cash offer to acquire all shares of Sweden's Abliva for 0.45 Swedish kroner ($0.04) per share.

The transaction is valued at about $66.1 million in cash.

Pharming ( PHAR ) said that Abliva's three largest shareholders, accounting for 49.8% of all shares, have already committed to accept the offer. Abliva's board has also unanimously endorsed the deal.

The acceptance period for the offer is expected to begin Jan. 16 and expire on Feb. 7, Pharming ( PHAR ) said.